Development Level

Tbio 63 | 10,625
Tdark 55 | 7,003
Tchem 20 | 1,890
Tclin 1 | 602

IMPC Phenotype

embryonic lethality prior to t... 3 | 187
abnormal lens morphology 2 | 73
abnormal tooth morphology 2 | 24
cardiovascular system phenotyp... 2 | 35
decreased lean body mass 2 | 195
enlarged heart 2 | 111
increased circulating choleste... 2 | 53
preweaning lethality, complete... 2 | 633
abnormal behavior 1 | 226
abnormal coat-hair pigmentatio... 1 | 54
abnormal embryo size 1 | 112
abnormal eye morphology 1 | 38
abnormal heart morphology 1 | 51
abnormal humerus morphology 1 | 11
abnormal incisor color 1 | 2
abnormal kidney morphology 1 | 30
abnormal limb bud morphology 1 | 15
abnormal pericardium morpholog... 1 | 11
abnormal sleep behavior 1 | 63
abnormal snout morphology 1 | 18
abnormal tibia morphology 1 | 14
cataract 1 | 26
decreased body length 1 | 108
decreased body weight 1 | 174
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased cardiac muscle contr... 1 | 5
decreased caudal vertebrae num... 1 | 49
decreased circulating glucose ... 1 | 121
decreased circulating serum al... 1 | 79
decreased circulating sodium l... 1 | 18
decreased fasted circulating g... 1 | 49
decreased heart rate 1 | 10
decreased heart weight 1 | 44
decreased mean corpuscular hem... 1 | 19
decreased mean corpuscular vol... 1 | 50
decreased total body fat amoun... 1 | 186
embryonic lethality prior to o... 1 | 148
enlarged heart atrium 1 | 2
enlarged spleen 1 | 26
increased circulating HDL chol... 1 | 63
increased circulating LDL chol... 1 | 15
increased circulating alkaline... 1 | 119
increased circulating bilirubi... 1 | 16
increased circulating free fat... 1 | 17
increased circulating triglyce... 1 | 24
increased grip strength 1 | 83
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 25
increased or absent threshold ... 1 | 128
male infertility 1 | 62
pallor 1 | 13

Disease

osteosarcoma 54 | 7,933
ovarian cancer 49 | 8,491
psoriasis 44 | 6,685
lung cancer 36 | 4,473
lung adenocarcinoma 30 | 2,714
medulloblastoma, large-cell 29 | 6,234
glioblastoma 28 | 5,572
non-small cell lung cancer 27 | 2,798
intraductal papillary-mucinous carcinoma (IPMC) 26 | 2,988
lung carcinoma 26 | 2,844
intraductal papillary-mucinous adenoma (IPMA) 25 | 2,956
invasive ductal carcinoma 25 | 2,950
tuberculosis 25 | 1,563
Breast cancer 24 | 3,098
pancreatic cancer 24 | 2,300
Cancer 23 | 2,346
intraductal papillary-mucinous neoplasm (IPMN) 23 | 3,289
pancreatic ductal adenocarcinoma liver metastasis 22 | 1,795
diabetes mellitus 20 | 1,663
ulcerative colitis 19 | 2,087
interstitial cystitis 18 | 2,299
atypical teratoid / rhabdoid tumor 17 | 4,369
ductal carcinoma in situ 17 | 1,745
juvenile dermatomyositis 17 | 1,189
primary pancreatic ductal adenocarcinoma 17 | 1,271
malignant mesothelioma 16 | 3,163
Carcinoma 15 | 2,147
adrenocortical carcinoma 15 | 1,427
breast carcinoma 15 | 1,614
mucosa-associated lymphoid tissue lymphoma 15 | 480
pilocytic astrocytoma 15 | 3,086
Atherosclerosis 14 | 275
colon cancer 14 | 1,475
Multiple myeloma 13 | 1,327
acute quadriplegic myopathy 13 | 1,157
astrocytoma 13 | 1,493
oligodendroglioma 13 | 2,849
pediatric high grade glioma 13 | 2,712
Duchenne muscular dystrophy 12 | 602
Kidney disease 12 | 397
chronic lymphosyte leukemia 12 | 232
cutaneous lupus erythematosus 12 | 1,056
Obesity 11 | 616
pituitary cancer 11 | 1,972
posterior fossa group A ependymoma 11 | 1,511
Alzheimer's disease 10 | 644
Rheumatoid Arthritis 10 | 1,170
dermatomyositis 10 | 966
periodontitis 10 | 269
posterior fossa group B ependymoma 10 | 1,530
subependymal giant cell astrocytoma 10 | 2,287
Coronary artery disease 9 | 240
Liver disease 9 | 219
Vascular disease 9 | 281
cystic fibrosis 9 | 1,670
ependymoma 9 | 2,514
esophageal adenocarcinoma 9 | 737
group 3 medulloblastoma 9 | 2,254
Anemia 8 | 252
Heart disease 8 | 279
Hypertension 8 | 293
Neurodegenerative disease 8 | 383
Waldenstrons macroglobulinemia 8 | 764
medulloblastoma 8 | 1,524
nephrosclerosis 8 | 329
primitive neuroectodermal tumor 8 | 3,031
Atopic dermatitis 7 | 944
Becker muscular dystrophy 7 | 187
Cardiovascular system disease 7 | 194
Chronic obstructive pulmonary disease 7 | 147
Lipid metabolism disorder 7 | 102
Prostatic Neoplasms 7 | 471
fibroadenoma 7 | 557
gastric carcinoma 7 | 832
group 4 medulloblastoma 7 | 1,875
pancreatic carcinoma 7 | 567
spina bifida 7 | 1,064
Amyloidosis 6 | 68
Asthma 6 | 349
Cardiovascular Diseases 6 | 50
Hypertensive disease 6 | 193
Leukemia 6 | 88
Lymphoma 6 | 57
Metabolic syndrome X 6 | 155
Parkinson's disease 6 | 364
Pick disease 6 | 1,893
astrocytic glioma 6 | 2,241
autosomal dominant Emery-Dreifuss muscular dystrophy 6 | 499
chronic rhinosinusitis 6 | 512
cystic fibrosis and chronic rhinosinusitis 6 | 213
Arthritis 5 | 248
Epilepsy 5 | 346
IGA Glomerulonephritis 5 | 454
Malaria 5 | 140
Stomach Neoplasms 5 | 282
adult high grade glioma 5 | 2,148
hepatocellular carcinoma 5 | 550
limb girdle muscular dystrophy 2A 5 | 156
primary Sjogren syndrome 5 | 788
sonic hedgehog group medulloblastoma 5 | 1,482

Tissue

Digestive Tract 124 | 18,472
Female tissues 124 | 18,646
Respiratory system 124 | 17,483
Blood and immune system 123 | 17,994
Liver and Pancreas 123 | 18,135
Skin and soft tissues 123 | 18,114
Urinary Tract 123 | 18,443
Cardiovascular System 122 | 17,957
Endocrine System 121 | 18,511
Nervous System 121 | 18,560
Male tissues 119 | 17,968

Target Family

Non-IDG 127 | 11,969
Enzyme 8 | 4,146
Kinase 3 | 634
GPCR 1 | 408

GO Process

receptor-mediated endocytosis 139 | 139
transcription, DNA-templated 1,779 | 1,779
regulation of transcription, D... 1,170 | 1,170
signal transduction 969 | 969
positive regulation of transcr... 845 | 845
G-protein coupled receptor sig... 666 | 666
negative regulation of transcr... 620 | 620
apoptotic process 506 | 506
positive regulation of transcr... 504 | 504
negative regulation of transcr... 483 | 483
multicellular organism develop... 456 | 456
positive regulation of cell pr... 451 | 451
cell differentiation 442 | 442
negative regulation of apoptot... 440 | 440
innate immune response 410 | 410
cell adhesion 409 | 409
immune response 398 | 398
negative regulation of cell pr... 379 | 379
inflammatory response 371 | 371
viral process 367 | 367
spermatogenesis 365 | 365
cell proliferation 358 | 358
protein transport 356 | 356
intracellular signal transduct... 355 | 355
cell division 330 | 330
regulation of transcription fr... 324 | 324
protein phosphorylation 320 | 320
response to drug 297 | 297
positive regulation of apoptot... 292 | 292
nervous system development 275 | 275
transcription from RNA polymer... 272 | 272
cell surface receptor signalin... 267 | 267
protein ubiquitination 260 | 260
transport 257 | 257
cell-cell signaling 249 | 249
regulation of immune response 247 | 247
positive regulation of gene ex... 242 | 242
mitotic nuclear division 241 | 241
chemical synaptic transmission 238 | 238
MAPK cascade 237 | 237
mRNA splicing, via spliceosome 219 | 219
angiogenesis 218 | 218
small GTPase mediated signal t... 215 | 215
translation 215 | 215
rRNA processing 209 | 209
intracellular protein transpor... 205 | 205
cellular response to DNA damag... 201 | 201
cell cycle 200 | 200
proteasome-mediated ubiquitin-... 199 | 199
proteolysis 199 | 199
visual perception 198 | 198
DNA repair 196 | 196
extracellular matrix organizat... 193 | 193
regulation of apoptotic proces... 190 | 190
brain development 183 | 183
positive regulation of cell mi... 181 | 181
protein polyubiquitination 180 | 180
in utero embryonic development 178 | 178
Fc-epsilon receptor signaling ... 175 | 175
Wnt signaling pathway 175 | 175
ion transmembrane transport 174 | 174
protein homooligomerization 173 | 173
heart development 170 | 170
positive regulation of ERK1 an... 170 | 170
blood coagulation 169 | 169
cell migration 168 | 168
regulation of cell proliferati... 167 | 167
protein autophosphorylation 166 | 166
response to hypoxia 164 | 164
mRNA processing 162 | 162
protein folding 162 | 162
negative regulation of canonic... 161 | 161
response to lipopolysaccharide 161 | 161
T cell receptor signaling path... 160 | 160
defense response to virus 160 | 160
RNA splicing 158 | 158
aging 158 | 158
positive regulation of I-kappa... 158 | 158
axon guidance 157 | 157
homophilic cell adhesion via p... 155 | 155
sensory perception of smell 155 | 155
ER to Golgi vesicle-mediated t... 151 | 151
interferon-gamma-mediated sign... 150 | 150
protein ubiquitination involve... 150 | 150
transcription initiation from ... 150 | 150
ubiquitin-dependent protein ca... 149 | 149
DNA replication 144 | 144
adaptive immune response 139 | 139
cell cycle arrest 139 | 139
skeletal system development 136 | 136
regulation of cell shape 135 | 135
regulation of small GTPase med... 134 | 134
G2-M transition of mitotic cel... 133 | 133
oxidation-reduction process 133 | 133
positive regulation of cytosol... 133 | 133
protein stabilization 133 | 133
sensory perception of sound 132 | 132
positive regulation of NF-kapp... 131 | 131
type I interferon signaling pa... 130 | 130
endocytosis 129 | 129

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Folate receptor alpha FOLR1 Tchem Non-IDG -2.27944 181.4 235
Low-density lipoprotein receptor LDLR Tchem Non-IDG -3.04462 893.1 512
Apolipoprotein B receptor APOBR Tbio Non-IDG -1.00321 11.5 113
Calreticulin CALR Tbio Non-IDG -3.16449 1423.9 650
TGF-beta receptor type-2 TGFBR2 Tchem Kinase -2.81736 519.3 441
Ig lambda-6 chain C region IGLC6 Tdark Non-IDG -1.81183 228.7 0
Collectin-11 COLEC11 Tbio Non-IDG -1.28501 18.8 91
Folate receptor beta FOLR2 Tchem Non-IDG -1.86286 82.1 165
Low-density lipoprotein receptor class A domain-containing protein 3 LDLRAD3 Tbio Non-IDG 0.08 1.45 100
Low-density lipoprotein receptor-related protein 1B LRP1B Tbio Non-IDG -1.51387 37.0 10